Orion Biotech Opportunities Corp.
NASDAQ: ORIA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Zuie-Chin Huang
- Headquarters
- New York City, United States
- IPO year
- 2021
- Website
- https://orionbiotechopportunities.com
Loading ORIA…
Loading profile data…Frequently asked questions about ORIA
What does Orion Biotech Opportunities Corp. (ORIA) do?
Orion Biotech Opportunities Corp. functions as a blank check company, meaning its primary goal is to undertake a business combination – such as a merger, acquisition of assets or shares, or a corporate reorganization – with one or more existing businesses. Established in 2021, the company is headquartered in New York, New York.
Where does ORIA trade?
Orion Biotech Opportunities Corp. (ORIA) trades on the NASDAQ Capital Market.
What sector is ORIA in?
Orion Biotech Opportunities Corp. (ORIA) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Orion Biotech Opportunities Corp.?
Zuie-Chin Huang is the chief executive officer of Orion Biotech Opportunities Corp. (ORIA).
Where is Orion Biotech Opportunities Corp. headquartered?
Orion Biotech Opportunities Corp. is headquartered in United States.
Does ORIA pay a dividend?
Orion Biotech Opportunities Corp. (ORIA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ORIA go public?
Orion Biotech Opportunities Corp. (ORIA) completed its initial public offering in 2021.